{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:08:23Z","timestamp":1791144503805,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972575"],"award-info":[{"award-number":["81972575"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273349"],"award-info":[{"award-number":["82273349"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["SQ2022YFA1300089"],"award-info":[{"award-number":["SQ2022YFA1300089"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.canlet.2023.216513","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T03:06:46Z","timestamp":1701140806000},"page":"216513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Spatial multimodal analysis revealed tertiary lymphoid structures as a risk stratification indicator in combined hepatocellular-cholangiocarcinoma"],"prefix":"10.1016","volume":"581","author":[{"given":"Xiaojie","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8464-3454","authenticated-orcid":false,"given":"Weiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216513_bib1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/lt.23897","article-title":"Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor","volume":"20","author":"Garancini","year":"2014","journal-title":"Liver Transplant."},{"key":"10.1016\/j.canlet.2023.216513_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.29789","article-title":"cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation","volume":"68","author":"Brunt","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2023.216513_bib3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.14309\/ajg.0000000000000326","article-title":"Combined hepatocellular cholangiocarcinoma: a population-based retrospective study","volume":"114","author":"Ramai","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canlet.2023.216513_bib4","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/jgh.14547","article-title":"Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers","volume":"34","author":"Wakizaka","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2023.216513_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jjco\/hyg056","article-title":"Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases","volume":"33","author":"Yano","year":"2003","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216513_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.humpath.2019.11.001","article-title":"Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma","volume":"96","author":"Sciarra","year":"2020","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2023.216513_bib7","series-title":"Digestive System Tumours","article-title":"WHO classification of tumours","year":"2019"},{"key":"10.1016\/j.canlet.2023.216513_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ctm2.11","article-title":"The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome","volume":"10","author":"Zheng","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216513_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/1078-0432.CCR-21-1219","article-title":"Immune profiling of combined hepatocellular- cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy","volume":"28","author":"Nguyen","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216513_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.canlet.2023.216513_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2023.216513_bib12","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-11-0431","article-title":"Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer","volume":"71","author":"Martinet","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216513_bib13","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28976","article-title":"Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses","volume":"3","author":"Goc","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2023.216513_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1378844","article-title":"Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer","volume":"7","author":"Posch","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2023.216513_bib15","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/bjc.2015.145","article-title":"Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer","volume":"112","author":"Hiraoka","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216513_bib16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41467-022-29040-x","article-title":"Tertiary lymphoid structures critical for prognosis in endometrial cancer patients","volume":"13","author":"Horeweg","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216513_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","article-title":"Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma","volume":"70","author":"Calderaro","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2023.216513_bib18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2023.216513_bib19","doi-asserted-by":"crossref","first-page":"eabg3750","DOI":"10.1126\/sciadv.abg3750","article-title":"Comprehensive analysis of spatial architecture in primary liver cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2023.216513_bib20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","article-title":"Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes","volume":"35","author":"Xue","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216513_bib21","series-title":"An End-To-End Workflow for Multiplexed Image Processing and Analysis","author":"Windhager","year":"2021"},{"key":"10.1016\/j.canlet.2023.216513_bib22","doi-asserted-by":"crossref","first-page":"39357","DOI":"10.18632\/oncotarget.5329","article-title":"The diagnostic and prognostic value of MRP8\/MRP14 in intrahepatic cholangiocarcinoma","volume":"6","author":"Jin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2023.216513_bib23","article-title":"Peritumoral tertiary lymphoid structures correlate with protective immunity and improved prognosis in patients with hepatocellular carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2023.216513_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1007426","article-title":"Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: new findings from a genetic perspective","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2023.216513_bib25","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/gutjnl-2021-324339","article-title":"Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny","volume":"71","author":"Sheng","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2023.216513_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.canlet.2023.216513_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00262-014-1544-9","article-title":"Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?","volume":"63","author":"Silina","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2023.216513_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216513_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13058-019-1148-6","article-title":"Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications","volume":"21","author":"Jezequel","year":"2019","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2023.216513_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/2326-6066.CIR-18-0758","article-title":"The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes","volume":"7","author":"Pfannstiel","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2023.216513_bib31","first-page":"794","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.canlet.2023.216513_bib32","first-page":"11","article-title":"Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases","author":"Zhang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216513_bib33","first-page":"647","article-title":"Combined liver cell and bile duct carcinoma","volume":"25","author":"Allen","year":"1949","journal-title":"Am. J. Pathol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523004640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523004640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:12:57Z","timestamp":1759594377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523004640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":33,"alternative-id":["S0304383523004640"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216513","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial multimodal analysis revealed tertiary lymphoid structures as a risk stratification indicator in combined hepatocellular-cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216513"}}